Close this search box.
Close this search box.

February 28, 2022

One to watch: The omnichannel ecosystem for medical affairs

Catch up with us on video from events you may have missed. In this edition, learn how medical affairs leaders are getting more value from the insights they collect.
Omnichannel insights strategy

One of the challenges pharmaceutical and medical device teams face is handling the volume of insights coming from multiple channels – advisory boards, medical conferences, one-to-one conversations with HCPs and patients, and other opportunities that span geographies and lines of business. To stay on top of all of this data, life science teams need a technology-enabled omnichannel insights strategy.

There are several steps teams can take now to improve insights management and accelerate the timeline for translating data into action. In a recent Evidence Life Science event, Within3’s Nina Levin, Vice President, Client Success spoke about how an omnichannel model for insight-gathering achieves these goals and ultimately contributes to improved outcomes for patients.

Speak to the right people

Pharma and medical device teams use input from a cross-section of stakeholders – from HCPs to patients, peers, and caregivers – to make business decisions. Precise expert selection and a more granular understanding of patients allow organizations to spend time getting a complete picture of the disease community or topic under discussion.

Design effective engagements

Once organizations identify relevant stakeholders, they must determine how to connect with them. A combination of real-time and asynchronous discussions offers patients and other stakeholders more flexibility around when and where they participate in insight-gathering discussions, as well as equal time to be heard. This approach typically results in higher-quality conversations that yield more relevant insights. Further, asynchronous virtual interaction enables more frequent touchpoints, so teams can foster deeper relationships with KOLs, patients, and other audiences.

Quickly identify focus areas

Lastly, once feedback has been collected from the discussion, teams need to understand, organize and share the insights to make the best strategic decisions possible. With manual processes, it could take months to gain an understanding of important topics. Now, technology enables a better way to more quickly grasp areas of focus or concern, so pharma and medical device teams can get a holistic view of insights and increase their decision-making power.

To hear real-world examples of how life science teams use technology to make more confident decisions, watch the video.

Related Posts:

Virtual meetings vs. virtual work

KOL identification

VEP Spotlight Series: HCA Group

technology for medical congresses

The 4 technologies that are changing medical congresses

More insights, direct to your inbox.